438 related articles for article (PubMed ID: 20624942)
1. Cbl-b(-/-) T cells demonstrate in vivo resistance to regulatory T cells but a context-dependent resistance to TGF-beta.
Adams CO; Housley WJ; Bhowmick S; Cone RE; Rajan TV; Forouhar F; Clark RB
J Immunol; 2010 Aug; 185(4):2051-8. PubMed ID: 20624942
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
3. Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice.
Wohlfert EA; Callahan MK; Clark RB
J Immunol; 2004 Jul; 173(2):1059-65. PubMed ID: 15240694
[TBL] [Abstract][Full Text] [Related]
4. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of TGF-βRII in T effector cells leads to increased resistance to TGF-β-mediated suppression of autoimmune responses in type I diabetes.
Kawamoto K; Pahuja A; Nettles A; Honkanen-Scott M; Bansal-Pakala P
Autoimmunity; 2012 Jun; 45(4):310-9. PubMed ID: 22390157
[TBL] [Abstract][Full Text] [Related]
6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
8. IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.
Prochazkova J; Pokorna K; Holan V
Immunobiology; 2012 Jan; 217(1):74-82. PubMed ID: 21903294
[TBL] [Abstract][Full Text] [Related]
9. T cell sensitivity to TGF-beta is required for the effector function but not the generation of splenic CD8+ regulatory T cells induced via the injection of antigen into the anterior chamber.
Cone RE; Chattopadhyay S; Sharafieh R; Lemire Y; O'Rourke J; Flavell RA; Clark RB
Int Immunol; 2009 May; 21(5):567-74. PubMed ID: 19325036
[TBL] [Abstract][Full Text] [Related]
10. TGF-β-dependent induction of CD4⁺CD25⁺Foxp3⁺ Tregs by liver sinusoidal endothelial cells.
Carambia A; Freund B; Schwinge D; Heine M; Laschtowitz A; Huber S; Wraith DC; Korn T; Schramm C; Lohse AW; Heeren J; Herkel J
J Hepatol; 2014 Sep; 61(3):594-9. PubMed ID: 24798620
[TBL] [Abstract][Full Text] [Related]
11. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.
Seki M; Oomizu S; Sakata KM; Sakata A; Arikawa T; Watanabe K; Ito K; Takeshita K; Niki T; Saita N; Nishi N; Yamauchi A; Katoh S; Matsukawa A; Kuchroo V; Hirashima M
Clin Immunol; 2008 Apr; 127(1):78-88. PubMed ID: 18282810
[TBL] [Abstract][Full Text] [Related]
12. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
13. Generation of highly effective and stable murine alloreactive Treg cells by combined anti-CD4 mAb, TGF-β, and RA treatment.
Schliesser U; Chopra M; Beilhack A; Appelt C; Vogel S; Schumann J; Panov I; Vogt K; Schlickeiser S; Olek S; Wood K; Brandt C; Volk HD; Sawitzki B
Eur J Immunol; 2013 Dec; 43(12):3291-305. PubMed ID: 23946112
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S
Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237
[TBL] [Abstract][Full Text] [Related]
15. Reinforcement of cancer immunotherapy by adoptive transfer of cblb-deficient CD8+ T cells combined with a DC vaccine.
Lutz-Nicoladoni C; Wallner S; Stoitzner P; Pircher M; Gruber T; Wolf AM; Gastl G; Penninger JM; Baier G; Wolf D
Immunol Cell Biol; 2012 Jan; 90(1):130-4. PubMed ID: 21383769
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
[TBL] [Abstract][Full Text] [Related]
17. Th17 cells: a new fate for differentiating helper T cells.
Chen Z; O'Shea JJ
Immunol Res; 2008; 41(2):87-102. PubMed ID: 18172584
[TBL] [Abstract][Full Text] [Related]
18. Impaired expansion of regulatory T cells in a neonatal thymectomy-induced autoimmune mouse model.
Yamada A; Ushio A; Arakaki R; Tsunematsu T; Kudo Y; Hayashi Y; Ishimaru N
Am J Pathol; 2015 Nov; 185(11):2886-97. PubMed ID: 26343329
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
20. Adoptive transfer of all-trans-retinal-induced regulatory T cells ameliorates experimental autoimmune arthritis in an interferon-gamma knockout model.
Jeon EJ; Yoon BY; Lim JY; Oh HJ; Park HS; Park MJ; Lim MA; Park MK; Kim KW; Cho ML; Cho SG
Autoimmunity; 2012 Sep; 45(6):460-9. PubMed ID: 22559266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
